Consensus XP Inc.

Equities

XP

KYG982391099

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
21.58 USD +0.19% Intraday chart for XP Inc. -3.62% -17.22%

Evolution of the average Target Price on XP Inc.

Price target over the last 5 years

History of analyst recommendation changes

7ba07ef863d91c3f.j9DzPkn_rfadrJP9y-AosxTr3osFaWTPuxP26cusNOs.3OirXwWp-6TtwKqRn7dO0mymsegwPwiJ4kvArYDUc6jWpd4ND6rPl__05A~5a6005884498dcf62b5eef0c64d1f5b6
XP Shares Decline After Goldman Sachs Downgrade MT
Goldman Sachs Downgrades XP to Neutral From Buy, Cuts Price Target to $23 From $30 MT
Morgan Stanley Downgrades XP to Equalweight From Overweight, Adjusts Price Target to $24 From $31 MT
Citigroup Adjusts Price Target on XP to $29 From $28, Maintains Buy Rating MT
UBS Adjusts XP Price Target to $30 From $31, Maintains Buy Rating MT
JPMorgan Upgrades XP to Overweight From Neutral, Raises Price Target to $30 From $27 MT
UBS Trims XP's Price Target to $31 From $33, Keeps Buy Rating MT
UBS Raises XP's Price Target to $33 From $28, Keeps Buy Rating MT
JPMorgan Adjusts Price Target on XP to $27 From $18.50, Maintains Neutral Rating MT
Citigroup Adjusts XP Price Target to $30 From $20, Maintains Buy Rating MT
Credit Suisse Upgrades XP to Neutral From Underperform, Adjusts Price Target to $26 From $15 MT
Goldman Sachs Adjusts Price Target on XP to $29 From $22, Maintains Buy Rating MT
BofA Securities Upgrades XP to Buy From Neutral MT
UBS Raises XP's Price Target to $28 From $21, Maintains Buy Rating MT
Bradesco BBI Downgrades XP to Neutral From Outperform, Adjusts Price Target to $17 From $25 MT
Goldman Sachs Adjusts Price Target on XP to $22 From $20, Maintains Buy Rating MT
UBS Adjusts XP Price Target to $21 From $28, Maintains Buy Rating MT
Goldman Sachs Cuts XP's Price Target to $20 From $30, Maintains Buy Rating MT
HSBC Adjusts Price Target on XP to $20 From $26, Maintains Buy Rating MT
Citigroup Adjusts XP Price Target to $19 From $24, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on XP to $35 From $40, Maintains Buy Rating MT
Brazilian broker XP's profit gains from higher client assets RE
UBS Adjusts XP Price Target to $28 From $31, Maintains Buy Rating MT
Goldman Sachs Raises Price Target on XP to $40 From $46, Keeps Buy Rating MT
JPMorgan Downgrades XP to Neutral From Overweight; Price Target is $23 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
111.2 BRL
Average target price
148.9 BRL
Spread / Average Target
+33.90%
High Price Target
167.3 BRL
Spread / Highest target
+50.41%
Low Price Target
117.6 BRL
Spread / Lowest Target
+5.73%

Consensus detail

Consensus revision (last 18 months)

Analysts covering XP Inc.

Goldman Sachs
Morgan Stanley
Citigroup
UBS
JPMorgan Chase
Credit Suisse
BofA Securities
Bradesco
HSBC
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW